This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) surged 18.47% to $9.11 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.24% to 4,350.65 and Dow Jones Industrial Average falling 0.34% to 34,378.34. This was the stock's second consecutive day of gains. Ocugen Inc. closed $9.66 below its 52-week high ($18.77), which the company reached on February 8th.
The stock outperformed some of its competitors Tuesday, as Adverum Biotechnologies Inc. (ADVM) rose 4.39% to $2.14, Ocular Therapeutix Inc. (OCUL) rose 7.29% to $12.07, and Kodiak Sciences Inc. (KOD) rose 1.46% to $105.85. Trading volume (104.9 M) eclipsed its 50-day average volume of 12.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 12, 2021.
(END) Dow Jones Newswires
October 12, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.